These findings correlate well with genetic, histological and bioinformatic analysis of human tissue samples, suggesting TRPM7 is aberrantly expressed in many cancer types and can serve as a prognosis marker of the disease progression and survival of the patients [52,53,54,55,56]. This evidence concerns the gene TRPM7 and cancer.